Simon Quick Advisors’s KALA BIO KALA Stock Holding History

Simon Quick Advisors’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4	Closed	-$75K	–	496
2020 Q3	$75K	Hold	4	–	–	0.02%	157
2020 Q2	$105K	Hold	4	–	–	0.04%	120
2020 Q1	$88K	Buy	+4	New	+$63.9K	0.03%	128

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simon Quick Advisors's KALA Position: Q4 2020 in Review

Simon Quick Advisors sold out of KALA BIO (KALA) in Q4 2020, closing a stake of 4 shares — an estimated $75K sold.

Simon Quick Advisors first reported a position in KALA in Q1 2020 and held it in 3 quarters. The position peaked at $105K in Q2 2020. 112 funds tracked by Wall St. Rank hold KALA as of Q4 2020.

Simon Quick Advisors reported no remaining KALA BIO position as of Q4 2020 after selling out during the quarter.
Simon Quick Advisors sold 4 KALA BIO shares in Q4 2020, an estimated $75K.
Simon Quick Advisors first reported a position in KALA BIO in Q1 2020 and held it in 3 quarters.
Simon Quick Advisors's KALA BIO position peaked at $105K in Q2 2020.
112 funds tracked by Wall St. Rank held KALA BIO as of Q4 2020.

Based on Simon Quick Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.